Leerink Swann & Company
Company Information
Boston, MA
United States
Phone: 1 617 248 1601
Fax: 1 617 918 4900
Overview
The proprietary knowledge of the MEDACorp network enhances every service offered by Leerink Swann. MEDACorp has amassed more than 25,000 healthcare experts, including key opinion leaders, experienced practitioners and other healthcare professionals throughout North America, Europe, Asia and around the world in fields including: - Clinical Medicine - Basic Sciences - Biomedical Research - Regulatory Affairs - Intellectual Property - Public Health and Policy - Managed Care - Pharmacy Management and Pharmacy Benefits Management - Healthcare Administration - Healthcare Facilities - Healthcare Information Technology - Allied Health Services - Healthcare Consulting Working with MEDACorp experts, Leerink Swann's clients and professionals gain access to preeminent expertise and opinions. This combination of competence in healthcare and capital markets powers Leerink Swann's knowledge platform and positions our clients for success. With this body of knowledge, we believe no investment bank can match the investment perspectives and insight of Leerink Swann. MEDACorp helps drive the success of:
Corporate Structure
CHIEF EXECUTIVE OFFICER
TOP EXECUTIVES
Stuart Barich Managing Director
Chris Kotowski Head of Institutional Equities
Robert M Whelan Trustee
David Ogens Senior Managing Director
Andrew Newman Treasurer, Senior Managing Director of Operations
John McPhee Managing Director
Vasilios M Kofitsas Senior Associate
Gary Nachman Director, Specialty Pharmaceuticals
Howard Liang Managing Director, Biotechnology
Ana Petrovic
Ann K Hynes Director
Michael J Ward Director
Mark Hochstetler
Bruce Cranna Managing Director, Medical Devices, Diagnostics
Roland Andersson Senior Managing Director, Corporate Consulting
Richard Brady
Stephen Zak Chief Financial Officer
Junaid Husain
William Tanner Managing Director, Biotechnology
Bret Jones Senior Associate, Health Care Technology & Distribution
Jonathan Fleming Managing Partner of Oxford Bioscience Partners
Richard N Pallan Board of Directors
John L Sullivan Director of Research
Joseph Schwartz Director, Biotechnology
Aaliyah El-Amin
Robert E. Cawthorn Managing Director of Global Health Care Partners of Dlj Merchant Banking Partners
Peter Day Vice President
Kenneth J. Novack Vice Chairman of Time Warner
Gregory Coleman Head of Institutional Equities
Daniel B Dubin Vice Chairman and Trustee of Leerink Swann & Company and Founder of Medacorp
Isaac Ro Associate
William F Sawyer
Jason Wittes Managing Director, Medical Devices, Cardiology and Orthopedics
Susanna Matter
Aileen Salares Vice President, Biotechnology
Jon A Civitarese Vice President, Corporate Finance, Capital Markets
Peter Flynn
Andrew M Oh
James M. Cornelius
Timothy A G Gerhold General Counsel and Senior Managing Director
Michael Weintraub Senior Managing Director and Head of Corporate Development and Strategy
Seamus Fernandez Director, Pharmaceuticals, Major
Carlo Casulo Senior Associate
Rafael Tejada Associate
George Hill Vice President
John B Kiernan Senior Managing Director and Head of Investment Banking
Kathryn Alexander Associate, Pharmaceuticals, Major
Alice Avanian Associate Director of Research, Managing Director
Jonathan Eckard Associate, Biotechnology
Kia Khaleghpour Senior Research Associate
David Delleo Associate
Joe Gentile Chief Administrative Officer
Rohit Vanjani
Stephen Weiss Senior Managing Director
Leerink Swann Outstanding Partner
Jonathan P Gertler MD as Managing Director, Head of Biopharma Investment
Jason Gurda
Yoori Lee Managing Director and Director, Medacorp Services
Spencer P Hoffman Officer
Michael Jenkins Senior Managing Director, Head
Rene Mora Managing Director and Chief Scientific Officer
Frederick Wise Managing Director, Medical Supplies and Devices
